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1. Introduction
Small-molecule-based manipulation of biomatter by means of
bio-orthogonal transformations has brought remarkable advan-
ces in the exploration of biological processes at the molecular
level. Generally, the goals of these biocompatible and chemo-
selective modulation schemes are to install various kinds of
labels onto some biomolecule of interest or to furnish these
biologically relevant species with artificial functionalities. The
concepts of bio-orthogonal chemistry were delineated by Ber-
tozzi and Saxon in the early 2000s.[1] Since then, several chemi-
cal reactions between unnatural functions fulfilling the criteria
of bio-orthogonality have been discovered or, most of the
time, rediscovered.[2] This was also the case with tetrazines and
strained ring systems. Boger and Sauer described the chemical
nature of tetrazines in the 1980s; however, it took about 30
years until Fox and Weissleder almost simultaneously discov-
ered the great potential that this chemistry offers from the
synthetic biological point of view.[3–5] Amongst bio-orthogonal
reactions, [4+2] cycloaddition between 1,2,4,5-tetrazines (s-tet-
razines, Tz) and various dienophiles (inverse-electron-demand
Diels–Alder (IEDDA) cycloaddition, also often termed the Car-
boni–Lindsey reaction) deserves a special credit (Scheme 1).[6]
Although the synthesis of the reagents is often laborious,
the excellent reaction rates, biocompatibilities and selectivity
make up for the pain and provide a catalyst-free chemistry
that really meets the demands of chemical-biology-driven
exploration of molecular biology processes. There are several
publications that provide guides to different segments of the
world of tetrazine-dienophile-based bioconjugation tech-
niques.[7] Here we place special emphasis on tetrazine-based
schemes for labelling of biopolymers with manipulated build-
ing blocks and do not go into detailed explanations of, for ex-
ample, reaction kinetics or synthetic advancements in reagents
because these are summarized well in excellent recent re-
views.[7]
1.1. Tetrazines
Over the years numerous tetrazines have been developed. The
driving force behind these developments was to find the fine
line between reactivity and physiological stability. Detailed
theoretical and synthetic studies investigated the reactivities of
tetrazines. Although the pioneering works always discussed
these reactions strictly within the context of IEDDA reactions,
recent theoretical studies questioned the validity of this view
by pointing out that reactions between tetrazines and suitable
dienophiles can also proceed in a normal electron-demand
manner.[8] However, in line with the frontier molecular orbital
(FMO) theory of IEDDA reactions, the reactivity of tetrazines is
increased when they possess lowered LUMO energies as a
result of the introduction of electron-withdrawing substituents
at their 3- or 6-positions, or both.[7] Despite the large number
of tetrazines developed, only a few biologically stable, routine-
ly accessible tetrazine frames are used. Scheme 2 summarizes
Bio-orthogonal labelling schemes based on inverse-electron-
demand Diels–Alder (IEDDA) cycloaddition have attracted
much attention in chemical biology recently. The appealing
features of this reaction, such as the fast reaction kinetics, fully
bio-orthogonal nature and high selectivity, have helped chemi-
cal biologists gain deeper understanding of biochemical pro-
cesses at the molecular level. Listing the components and dis-
cussing the possibilities and limitations of these reagents, we
provide a recent snapshot of the field of IEDDA-based biomo-
lecular manipulation with special focus on fluorescent modula-
tion approaches through the use of bio-orthogonalized build-
ing blocks. At the end, we discuss challenges that need to be
addressed for further developments in order to overcome
recent limitations and to enable researchers to answer biomo-
lecular questions in more detail.
Scheme 1. General scheme of IEDDA reactions.
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a set of bio-orthogonally relevant tetrazine derivatives (1–6)
that are routinely applied in labelling schemes. Besides elec-
tronic features, steric effects should also be taken into account,
as recently pointed out by others and by ourselves.[9] There are
cases in which steric demand of the substituents overrules the
predicted order of reactivities.[10] It should also be noted that
despite the fact that IEDDA reactions are only slightly affected
by the polarity or ionic strength of the solvent, the reaction is
greatly accelerated in aqueous media, due to hydrophobic ef-
fects.
1.2. Dienophiles
According to the FMO theory of IEDDA reactions, use of dieno-
philes with raised HOMO energies accelerates reaction rates.[7]
This is generally achieved by placing electron-donating sub-
stituents on the dienophile or by introducing strain. It can be
said that fine tuning reactivity and stability in IEDDA schemes
in combination with the few generally applied tetrazines is
easier from the dienophile side. In general, strained alkenes or
alkynes are used (e.g. , norbornenes, cyclooctynes, trans-cyclo-
octenes (TCOs) and cyclopropenes) ; however, vinylboronic
acids have recently also been reported to be suitable moieties
for dienophiles. Just like tetrazines, these dienophiles should
meet the criteria for stability and reactivity under physiological
conditions. Detailed kinetic investigation by Sauer in the late
1990s indicated that the fastest IEDDA reactions are offered by
dienophiles with strained eight-membered ring systems.[3a]
As a consequence, the largest group of dienophiles is repre-
sented by cyclooctynes and TCOs. Besides participating in
IEDDA reactions, these strained ring systems are also prone to
react with nucleophiles, especially with free thiols such as GSH,
not to mention that, for instance, TCOs can isomerize to their
corresponding, much less reactive cis forms either spontane-
ously or by a thiol-mediated route. This sometimes suggests
the use of less reactive dienophiles in combination with more
reactive tetrazines or vice versa.
Nevertheless, the physiological stability of dienophiles
should always be investigated individually prior to use for a
given purpose. The very first bio-orthogonal examples were
presented almost simultaneously by the Weissleder and the
Fox groups. The former group applied a commercially accessi-
ble norbornene scaffold in IEDDA-based labelling schemes
with reaction rates at around k2=1.9 and 1.6m
@1 s@1 for the
two isomers of norbornene.[5] Fox and co-workers, on the
other hand, used functionalized dipyridyl-tetrazine 1
(Scheme 2) and a diastereomeric mixture of 5-hydroxy-TCO
(TCO), which showed impressive second-order rate constants
[k2= (22600:40) and (80200:200)m@1 s@1 for the two diaste-
reomers] .[4, 11] They also developed a continuous-flow photo-
chemical apparatus for the efficient conversion of cis-cyclooc-
tenes into trans-cyclooctenes.[12] Later, the same authors dis-
covered that forcing the crown/“half-chair” conformational
equilibrium of the TCO ring towards the more reactive “half-
chair” conformation through cis-ring fusion (to give s-TCO,
Scheme 2, a bicyclo[6.1.0]non-4-ene) greatly enhanced reaction
speed [k2= (3300000:40000)m@1 s@1] .[11,13] A more water-solu-
ble bicyclic TCO in which the TCO ring was fused to a dioxolane
unit (d-TCO) was also introduced by the Fox group.[11] Very im-
portantly, the two accessible diastereomers of d-TCO did not
show such large differences in reaction rates towards the tetra-
zine as diastereomers of the original TCO (Scheme 2).
Although the use of these TCOs was demonstrated on
chemically modified isolated proteins, the need for TCO-bear-
ing noncanonical amino acids (ncAAs) initiated the develop-
ment of new TCO derivatives. At this point cyclooctyne (e.g. ,
SCO, Scheme 2) and bicyclo[6.1.0]non-4-yne (BCN) frames, for-
merly developed for strain-promoted azide–alkyne click reac-
Scheme 2. Dienophiles, with second-order rate constants (k2 [m
@1 s@1] in
water) measured with tetrazines indicated in parentheses.
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tions (SPAAC) also started to play a role in IEDDA schemes.[14–16]
To increase stability and applicability in biological assays,
Lemke and Schultz developed new variants of the original TCO
frame. These derivatives carried the hydroxy substitution closer
to the double bond (TCO* and TCO#) than in TCO.[16] Stability
studies indicated that TCO* is much more stable than TCO#. Ki-
netic studies showed that TCO* reacts with a sterically less hin-
dered tetrazine (H-Tz, 3a) with second-order rate constants of
around 35900 and 12080m@1 s@1 for the axial and equatorial
atropisomers, respectively.[16b] With a sterically more hindered
tetrazine (Me-Tz, 3b) this was found to be two orders of mag-
nitude slower for the more reactive (yet more stable) isomer,
which could be accessed selectively.[16b]
Although not closely related to the topic of this review, it is
worth mentioning that TCO* has also been used as a decaging
scaffold in the context of IEDDA-based release of a chemothera-
peutic agent or in the site-specific unmasking of the e-amino
group of Lys residues in proteins.[16c,d]
Hydrophilicity of TCOs is a quite an issue, especially in live-
cell labelling experiments because removal of unincorporated
excess hydrophobic TCO-bearing tags from the cytosol re-
quires intensive and numerous washing cycles. This is in partic-
ular a problem when high concentrations of TCOs are used:
that is, during metabolic or genetic-code-expansion-based
incorporation of modified building blocks. Labelling of the re-
maining TCOs bound non-specifically to hydrophobic surfaces
leads to background signal, thus lowering signal-to-noise
ratios. In a joint work with the Lemke group we have demon-
strated that use of the hydrophilic TCO DOTCO (Scheme 2) can
eliminate this problem.[17] It is worth mentioning that DOTCO
showed only moderate reactivity towards the reactive 3a [k2=
(6370:80)m@1 s@1] , which could be partly due to reduced hy-
drophobic effects.
The requirement for lower perturbation of biological struc-
tures raised the need for the development of smaller dieno-
philes. This led to the synthesis of cyclopropenes for use as di-
enophiles in IEDDA schemes. Devaraj and, later, Prescher inves-
tigated the structure–reactivity relationships of differently func-
tionalized cyclopropene scaffolds.[18,19, 43] Cyclopropenes tend
to polymerize and also to be prone to attack by nucleophiles.
Both groups concluded that 1-methyl substitution of the cyclo-
propene framework overcomes this problem efficiently, provid-
ing suitable platforms without compromising reactivity, al-
though the IEDDA reactivity of cyclopropenes towards tetra-
zines is orders of magnitudes lower than that of eight-mem-
bered ring systems. A further dienophile moiety is represented
by acylazetines, in which the strain is less dominant, but the
enamine moiety facilitates reaction with tetrazines to reach re-
action rates similar to those achieved with cyclopropenes.[20]
In some instances, simple vinyl-derived building blocks have
also been found to be suitable for biomolecular tagging
schemes with tetrazines.[21]
A very recent work by Bonger et al. demonstrated that vinyl-
boronic acids are versatile scaffolds in IEDDA chemistry.[22] The
reactivity of the vinyl group is boosted by the weakly electron-
donating boronic acid moiety, and this is even more profound
in aqueous media, in which the boron hybridizes to a negative-
ly charged, strongly electron-donating group. Detailed mecha-
nistic and kinetic studies revealed a vinylboronic acid deriva-
tive that showed a second-order rate constant k2= (27:
2)m@1 s@1 in combination with a derivative of 6. Moreover, the
boronic acid moiety renders this dienophile stable, hydrophilic
and nontoxic. It should be noted, however, that vinylboronic
acids have not yet been applied in live-cell labelling experi-
ments, due to their possible side reactions with vicinal diols
(e.g. , sugars). Scheme 2 summarizes the structures of these di-
enophiles together with second-order rate constants of IEDDA
reactions with the indicated tetrazines.
From these examples it can be concluded that the vast vari-
ety of possible tetrazine/dienophile combinations allows re-
searchers to choose the ones that best suit the scope of the
given investigation.
1.3. Small-molecule probes in IEDDA labelling schemes
The beneficial features of reactions between tetrazines and,
mainly, strained alkenes/alkynes have borne fruit in various
biomolecular labelling schemes. The fast and efficient reactions
enable the use of labels with short half-lives and even the tag-
ging of species with short circulation times or rapid turnovers.
Different non-invasive imaging methods have used Diels–
Alder-based bio-orthogonal labelling schemes in cells or in live
animals to identify or localize biomolecules, to visualize pro-
teins at super-resolution level, to detect miRNA, to image tu-
mours or to track systemic metabolism processes.
Bio-orthogonal labelling methods follow a two-step, sequen-
tially driven scheme. Firstly, a bifunctional unnatural handle,
called a chemical reporter, is installed onto the biomolecule of
interest. The chemical reporter that carries a bio-orthogonal
function (i.e. , a dienophile or a tetrazine in the context of this
review) can be incorporated into the biomolecule of interest
either synthetically (e.g. , in the case of pretargeting antibodies)
or by means of enzymatic tagging, genetic code expansion or
the metabolic machinery of the system investigated. After at-
tachment of the bio-orthogonal function, the biomolecule
modified with the chemical reporter tag can be selectively tar-
geted with small-molecule probes incorporating the comple-
mentary bio-orthogonal function.
Radiolabels and fluorescent labels are generally used in
IEDDA-based bio-orthogonal labelling schemes; however,
some examples also use this chemistry to introduce magnetic
resonance (MR) contrast agents. In the case of radiolabelled
markers, tetrazine chemistry has been used by several groups
to install 18F- or 11C-labelled PET tracers onto bioactive moieties
or drugs.[23] The fast reaction speeds have allowed straightfor-
ward introduction of the radiolabels in low dosages. Other ra-
diolabels such as metallated probes (e.g. , 64Cu, 111In, 177Lu, 68Ga)
have also been applied. In these cases, together with that of
Gd-based MR contrast agents, chelators (e.g. , DOTA) are conju-
gated to cyclooctenes or tetrazines.[24]
Amongst imaging modes, however, fluorescent labelling by
means of bio-orthogonal installation of small-molecule fluoro-
phores is by far the dominant method of choice. The populari-
ty of fluorescence-based detection could be due to its relative-
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ly easy and cheap nature or to its excellent sensitivity, together
with its good spatial and temporal resolution. The poorer con-
trast of fluorescence images can be improved either by combi-
nation with, for example, PET imaging or by means of super-
resolution fluorescence technology. In the context of fluores-
cence imaging techniques, the sensitivity and resolution of
imaging are most commonly limited by autofluorescence of
naturally occurring fluorophores and nonspecific background
fluorescence of unreacted probes.[25] More and more attempts
to overcome these problems have appeared lately, as well as
attempts to design fluorescent labels that are suitable for
super-resolution technologies. Fluorescent probes possessing
large Stokes shifts or those that can be excited in the red/
near-infrared regime can diminish autofluorescence, whereas
so-called fluorogenic dyes efficiently reduce nonspecific back-
ground signal. Besides simple probes in which a tetrazine unit
is linked flexibly to a fluorescent label, the tetrazine moiety is
also suitable for the construction of fluorogenic dyes because
it is capable, in a suitably designed setup, of efficiently
quenching fluorescence.[16,26] Upon reaction with their target
dienophile the quenching effect is abolished and the fluores-
cence is reinstated. Although the exact quenching mechanisms
in these examples were only assumed in the works by the au-
thors, and the exact means of quenching are still debated, two
mechanisms are proposed in general. Tetrazines are able to
diminish the fluorescence of fluorescent cores either by FRET
or by a through-bond energy transfer (TBET) process
(Scheme 3).[27,28]
In FRET-based quenched systems the fluorescent core is
linked to the tetrazine through a flexible linker. Besides other
criteria (e.g. , distance, alignment of transition moments), FRET
systems require considerable overlap between the emission
spectrum of the fluorophore and the absorption band of the
tetrazine (typically falls between 520–540 nm). In TBET-based
fluorogenic probes the fluorophore and the tetrazine are at-
tached together through a rigid, conjugated, but otherwise
electronically decoupled (twisted) linker. Most importantly,
quenching through a TBET mechanism does not require any
spectral match between the fluorophore and the quencher, so
virtually any kind of fluorophore can be used. Although the
exact mechanism of TBET is still disputed and predictions are
limited, a TBET mechanism, with optimal design, is able to
reduce fluorescence more efficiently than a FRET one, and the
increase in fluorescence signal upon conjugation can reach as
much as three orders of magnitude (10–50-fold vs. 100–10000-
fold enhancements of fluorescence through FRET and TBET,
respectively). Finally, it should be noted that in TBET-based sys-
tems a parallel FRET effect is also existent, though this is a
much slower process.
In the subsequent sections we show recent advancements
in the use of tetrazine- or dienophile-modified biopolymeric
building blocks as chemical reporters, together with examples
of complementarily functionalized labels, with emphasis on
fluorescent labels.
2. Nucleotide Labelling
Nucleic acids (DNA and RNA) have essential roles in biological
systems; they carry the genetic material of each cell of a living
organism, so their study, detection and modification is a major
goal of chemical biology. Nucleic acid modifications by means
of solid-phase oligonucleotide synthesis from phosphoramidite
building blocks, of polymerase-assisted biochemical pathways
or of post-synthetic methodologies are versatile tools in ex-
ploring, elucidating and imaging DNA/RNA functions.
The field of IEDDA reactions with bio-orthogonalized nucleic
acids was pioneered by the J-schke group, who described the
very first examples of DNA modification through IEDDA reac-
tions based on norbornene-modified deoxyuridine dienophiles
(e.g. , building block 7, Scheme 4) that were effectively incorpo-
rated into oligonucleotides during solid-phase synthesis.
These manipulated oligonucleotides were used as primers to
amplify a double-stranded 109-mer DNA through a polymerase
chain reaction (PCR) approach. The workflow yielded products
modified with one, two or three norbornene-based dienophiles
Scheme 3. Some representative examples of synthetic small-molecule fluo-
rescent tetrazine probes. A) No spectral constraints between the fluorophore
and the tetrazine linked together with a flexible linker. B) Fluorogenic FRET
probes in which the spectrally matching fluorophore is linked to the tetra-
zine through a flexible linker. C) Fluorogenic TBET probes in which the fluo-
rophore is linked to the tetrazine through a rigid linker.
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that served as handles for biotinylation with a biotinylated
conjugate of tetrazine 6. This approach was further expanded
to label RNA, in an approach based on norbornene-guanosine
building blocks (e.g. , building block 8 in Scheme 4) that were
incorporated either chemically by solid-phase synthesis into a
19-mer RNA or enzymatically by a 5’-initiation protocol with T7
RNA polymerase.[29] The same group also reported the first
combination of the fully orthogonal CuAAC and IEDDA for si-
multaneous site-specific double-labelling of DNA oligonucleo-
tides, in a work that emphasized the superior reactivity of
TCO-based dienophiles.[30]
Kath-Schorr et al. demonstrated that IEDDA could be effec-
tively performed on RNA in mammalian cells. Their work in-
cluded the incorporation of a norbornene-guanosine derivative
(building block 8, Scheme 4) as a phosphoramidite at specific
positions in RNA during solid-phase synthesis. To validate the
concept, cells were transfected with a manipulated small inter-
fering RNA (siRNA; the sense strand bearing the norbornene
moiety, the antisense strand containing an ATTO647 fluoro-
phore) and subsequently incubated with a fluorescent conju-
gate of tetrazine 3. Showing that the reactivity depends not
only on the tetrazine derivatives but also on steric effects, dif-
fusion and cell permeability, the labelling of the fixed cells
proved to be successful because the product of the click reac-
tion resulted in strong turn-on fluorescence that colocalized
with the ATTO647-labelled siRNA. They concluded that the
methodology might be a useful tool for detection of RNA func-
tions in cells.[31]
Royzen et al. described another general approach to fluores-
cent labelling of RNA strands using a cytidine analogue deriv-
atized with the TCO group (building block 9, Scheme 4). The
TCO moiety was attached to position 5 of the nucleobase to
preserve enzymatic recognition, and the resulting derivative
was incorporated into the model strand by use of T7 RNA
polymerase. Fluorescein-modified tetrazine 3b served as tag to
label the synthetic RNA strand.[32]
Polymerase-mediated incorporation of TCO-modified (at po-
sition 5’) thymidine triphosphate (building block 10, Scheme 4)
into DNA was reported by Wang et al. Through IEDDA reac-
tions with suitably derivatized tetrazines, incorporation of a
boronic acid group or a fluorophore was also demonstrated.
Notably, boronic-acid-labelled DNA can be a new candidate for
aptamer selection against carbohydrates and glycoproteins.[33]
With a similar synthetic approach, Brown et al. incorporated
two TCO-modified deoxyuridine moieties with different linkers
between the TCO and uracil base along with a 5-azidomethyl-
2’-deoxyuridine unit into DNA. On comparison, the 5-azido-
methyl derivative proved to be a better substrate for poly-
merases than the two TCO-bases; however, the efficiency of
the IEDDA reactions between the TCOs and Cy3-3 dye was
found to be much more satisfactory than that of the strain-
promoted azide–alkyne click reaction between the azide and
a BCN-Cy3 fluorophore.[34]
The most compelling argument for the addition of TCO or
norbornene motives into DNA/RNA is the remarkable reaction
kinetics these dienophiles can undoubtedly offer. Still, incorpo-
ration of these rather bulky substituents into nucleosides
might inhibit their natural cellular metabolism and thus cause
DNA damage. Luedtke et al. addressed this challenge by iden-
tifying 5-vinyl-2’-deoxyuridine (VdU, building block 12,
Scheme 5) as the smallest possible moiety that could transform
nucleosides into efficient dienophiles and thus be a potential
metabolic label for DNA without perturbing any original func-
tion or causing cell cycle arrest. Although the rate of the reac-
tion between the vinyl group and the tetrazine was found to
be slower than those reported for strained olefins, it was quite
comparable with those of SPAAC reactions. When added to
the medium, the probe was selectively incorporated by endog-
enous enzymes into the genomes of replicating cells, where it
was detected by alkene–tetrazine ligation with a TAMRA-1 con-
jugate, resulting in rapid intranuclear staining. It was also es-
tablished that VdU is incorporated selectively into cellular DNA
and not RNA, because there was no evidence of detectable
VdU labelling in the presence of the DNA synthesis inhibitor
aphidicolin. The results underlined that strained cycloalkenes
are not always prerequisites for effective intracellular label-
ling.[35] Marx et al. reported a similar methodology, by synthe-
Scheme 4. Bio-orthogonalized building blocks for chemical or enzymatic in-
corporation of strained dienophiles. Post-synthetic modification of DNA and
RNA by IEDDA cycloaddition with various tetrazines bearing fluorophores,
biotin or boronic acid groups.
Scheme 5. Vinyl-type building blocks. VdU (12) was demonstrated to be an
efficient metabolic probe for cellular DNA imaging. DNA modified with DvinA
(11) was tagged with biotin-tetrazine conjugate.
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sising deoxyuridine (dvinU) and deoxydeazaadenosine (dvinA)
derivatives each bearing a vinyl group that points towards the
major groove of the DNA duplex to be accessible by labelling
reagents. DvinA (building block 11, Scheme 5) was found to be
more reactive than dvinU, having a second-order rate constant
of k2=0.010m
@1 s@1, thus implying that IEDDA reaction of vinyl
groups are comparable with SPAAC or Bertozzi–Staudinger li-
gations in terms of kinetics. DvinA was demonstrated to substi-
tute natural dATP in PCR completely, and the DNA product
was effectively tagged with a biotin-6 conjugate.[36]
Like vinyl derivatives, cyclopropenes are also small moieties;
however, they possess better reactivity, which makes them
potent candidates for DNA/RNA building blocks.
Kath-Schorr and Eggert described the first cyclopropene-
modified ribonucleotide, which was introduced into RNA at
predefined sequence positions. The fully replicable and tran-
scribable unnatural TPT3-dNAM base pair system was modified
with a methylcyclopropenyl system on the ribose TPT3 unit
(TPT3CP, building block 13, Scheme 6).[37] Enzymatic in vitro
transcription led to successful site-specific incorporation of the
cyclopropene moiety, followed by labelling with a fluoro-
phore–3a conjugate. In vitro transcription and post-transcrip-
tional labelling of a tRNA in the anticodon loop was also dem-
onstrated.[38]
A similar, T7-assisted in vitro transcription based on the
same unnatural hydrophobic base pairing system was used to
modify RNA oligonucleotides with norbornene moieties
(NorUB, building block 14, Scheme 6). Both of these examples
could offer a facile tool for studying RNA constructs with com-
plex folding pathways, such as ribozymes and aptamers.[39]
As illustrated by the above examples, nucleic acid labelling
through IEDDA cycloaddition mostly proceeds through incor-
poration of the dienophile into the DNA or RNA, followed by
post-synthetic attachment of a tetrazine probe. The reason
behind this is the general instability of tetrazines under the
conditions of chemical DNA synthesis. Still, the incorporation
of tetrazines into DNA is an open possibility, as demonstrated
by Wagenknecht and Kele in a study that revealed that steric
demand of substituents plays a prominent role in the Diels–
Alder reactivity of electron-deficient tetrazines. The tetrazine-
modified building block 15 (Scheme 7) was incorporated into
a DNA sequence, followed by on-bead labelling with cyclooc-
tyne-modified fluorescein.[10] The same authors also reported
that tetrazine building blocks 16 and 17 can be incorporated
as 2’-deoxyuridine derivatives into oligonucleotides by using
standard DNA polymerases (Hemo KlenTaq, KOD XL, Vent,
Deep Vent). The resulting full-length primer extension products
were labelled with cyclooctyne-modified fluorophores.[40]
The area of oligonucleotide-templated ligation reactions has
been extended to IEDDA applications by the Devaraj group.
They developed DNA/RNA template-dependent fluorogenic li-
gation between oligonucleotides capped at the 5’-end with a
quenched fluorophore-tetrazine unit (tetrazine building block
18, Scheme 7) and oligonucleotides bearing a cyclopropene
unit (building block 19, Scheme 8) at the 3’-end. The close
proximity of the reactive counterparts and the presence of an
antisense oligonucleotide template resulted in an increase in
Scheme 6. Building blocks from the toolbox of unnatural base pair genetic
code expansion.
Scheme 7. Tetrazine-based nucleic acid building blocks.
Scheme 8. Schematic and building blocks for template-driven oligonucleo-
tide labelling through modified DNA ligation, catalysed by hybridization
against a template strand. Reprinted from ref. [42], with permission. Copy-
right: 2014, American Chemical Society.
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the effective molarity (50–120 mm), a condition that allowed
reactions to proceed rapidly only in the presence of sequence-
specific targets, thus resulting in large increases in fluores-
cence.[41]
An interesting aspect of this template-driven IEDDA applica-
tion is that the product of cycloaddition has higher affinity for
the oligo template than the corresponding precursors, thus im-
peding further signal amplification or reaction turnover. Re-
garding this disadvantageous aspect as requiring further im-
provement, Devaraj et al. used a 7-azabenzonorbornadiene de-
rivative (building block 20, Scheme 8) with an alkenyl-tetrazine
fluorogenic probe; this demonstrated better performance, ena-
bling imaging of microRNA in living human cancer cell lines
(Scheme 8).[42]
3. Fluorescent Labelling of Lipids
Lipids (waxes, sterols, vitamins, glycerides and phospholipids,
among others) are important mainly in energy storage and in
signalling pathways and in acting as structural elements of cell
membranes. Although several examples have described the
use of bio-orthogonal chemistry in various lipid imaging
schemes, the number of those involving IEDDA reactions is
surprisingly low.
Devaraj et al. studied the suitability of stabilized, yet reactive
cyclopropene tags (building block 21, Scheme 9) for live-cell
imaging, by labelling modified phospholipids with fluorogenic
dyes. The cyclopropene handles elicited quick fluorescent re-
sponses from the quenched tetrazine dye BODIPY–4a, making
it possible to visualize efficiently the distribution of the tagged
phospholipids in SKBR3 cells.[43]
A remarkable lipid-based approach to visualizing the struc-
ture and dynamics of the Golgi apparatus also relied on the
IEDDA reaction. This strategy used the TCO-modified ceramide
lipid Cer-TCO (building block 22, Scheme 9) and fluorophore-
tetrazine conjugate SiR–3a together with their click product,
the extremely photostable “vital dye” Cer-SiR. The study con-
cluded that Cer-TCO accumulated in the Golgi without disturb-
ing cell morphology and then reacted with SiR-3a, thus ena-
bling selective visualization of the Golgi apparatus in HeLa
cells co-expressing GFP-modified fusion protein GaLNAcT2 as
Golgi marker for colocalization.
Monitoring of trafficking both through and within the Golgi
by means of a ratiometric inside/out assay verified that the or-
ganelle remained functional after IEDDA because the addition
of Cer-TCO and SiR-3a had no effect on the mobility of pro-
teins inside the Golgi or on cargo traffic from the ER to the
plasma through the apparatus. Cer-SiR also proved to be ex-
tremely photostable and thus an ideal candidate for stimulated
emission depletion (STED) microscopy (Figure 1).[26b]
4. IEDDA Labelling of Proteins through Genet-
ic Encoding of Noncanonical Amino Acids
Proteins play central roles in the majority of biological process-
es: they function as receptors and transporters and also serve
as enzymes or structural elements. Current methodologies for
fluorescent labelling of protein targets rely mostly on fluores-
cent proteins (GFP, CFP, YFP, mCherry etc.). However, due to
their large size (>20 kDa) and only moderate photostability,
there is more and more interest in approaches based on small-
molecule fluorescent systems. A convenient method is the use
of other fusion proteins such as self-labelling tags or enzymes
(e.g. , SNAP-tag, Halo-tag, CLIP-tag, tetracysteine-tag). They are
smaller than GFP analogues and enable the use of small-mole-
cule fluorescent probes with high specificity. An alternative la-
belling method makes use of engineered enzymes that recog-
nize peptide sequences fused to the proteins of interest (POIs;
e.g. , phosphopantheinyl-transferases, biotin ligase, lipoic acid
ligase, sortase, etc.). Although these methods are suitable for
site-specific modification of proteins, introduction of shorter or
Scheme 9. Lipid building blocks for tagging phospholipids (left) or visualis-
ing the Golgi apparatus (right).
Figure 1. Super-resolution imaging of the Golgi in live cells with the aid of
Cer-Sir. A) Confocal and STED images of the Golgi in live cells treated with
Cer-TCO and SiR-3a. Line traces through the Golgi (yellow) show the greatly
improved resolving power of STED (right-hand panel). B) Kymo-graphs (line
profile vs. time) of fixed cells imaged by STED in which the Golgi were la-
belled with Cer-SiR or Rab6-SNAP-SiR (Rab6 is a Golgi-targeted protein);
note that the signal decays much more quickly when the protein is labelled
with SiR. C) Time-lapse STED of vesicle budding and trafficking out of the
Golgi (green arrowhead). Reproduced from ref. [26b], with permission. Copy-
right: 2014, John Wiley & Sons, Inc.
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longer peptide sequences into a POI can disturb its structure
and/or function.[44]
Modification of proteins through incorporation of designer
amino acids provides an increasingly useful tool for studying
protein structure and function. Incorporation of amino acids
modified with bio-orthogonal functions provides a versatile
platform for fluorescent labelling through Diels–Alder cycload-
dition. Amino acids bearing unconventional functional groups
have been incorporated into proteins by a range of methods,
including solid-phase synthesis, native chemical ligation, and in
vitro translation.[45] However, these methods are limited only to
in vitro applications. In live cells, modified amino acids can be
incorporated into proteins in a residue- or a site-specific
manner. Numerous applications of copper-catalysed 1,3-cyclo-
additions in residue-specific unnatural amino acid incorpora-
tion to label whole proteomes of cells have been reported. To
the best of our knowledge, however, IEDDA reactions have not
yet been applied in this context.[46] Here we review recent
developments in site-specific IEDDA protein labelling through
genetic encoding of ncAAs.
In genetic code expansion technology, amino acids modified
with a unnatural—bio-orthogonal, for example—function are
introduced into the growing polypeptide chain during transla-
tion in response to an assigned, usually amber, STOP codon. To
insert large functional groups appended from the amino acid,
engineered aminoacyl tRNA synthetase/tRNA pairs are used.
The method and the development of genetic code expansion
have been extensively reviewed by others, so we focus only on
IEDDA-related works.[44b,47] Encoding of ncAAs into proteins is
achieved with the aid of several engineered tRNA synthetas-
e(RS)/tRNA pairs: the Methanococcus jannaschii tyrosyl-RS/tRNA
pair, the Escherichia coli tyrosyl-RS/tRNA pair and the E. coli
leucyl-RS/tRNA pair. These pairs each recognize one of the 20
natural amino acids; therefore, their active sites have to be
mutated for specificity towards the particular ncAA by directed
evolution approaches.
On the other hand, pyrrolysine RS/tRNA (PylRS/tRNAPyl) from
the prokaryote Methanosarcina species customarily recognizes
pyrrolysine, an amino acid not used by most prokaryotic
and eukaryotic organisms, and it is orthogonal in bacteria,
yeast, eukaryotic cells and animals. Wild-type and engineered
PylRS/tRNAPyl pairs with expanded binding pockets are used to
incorporate numerous bio-orthogonalized ncAAs into pro-
teins.[48]
The first example of genetic encoding of a strained-dieno-
phile-modified amino acid was reported in 2011 by Plass
et al.[49] Simple cyclooctynyllysine (simple cyclooctye, SCO) de-
rivatives 23 and 24 (for structures of ncAAs, see Scheme 10)
were encoded into GFP modified with an amber STOP codon
(GFPY39TAG) by using an engineered Y306A/Y384F mutant PylR-
SAF/tRNAPyl pair in E. coli. This two-site mutation was introduced
to support recognition of the bulkier side chain on the amino
acid.[50] The first IEDDA reactions with genetically encoded
ncAAs were presented in 2012 by the same group. Cyclooc-
tyne (23), norbornene (25 and 26) and trans-cyclooctene (27)
residues were encoded into GFP by use of the PylRSAF/tRNAPyl
pair in E. coli.[51] Intracellular fluorescent labelling was per-
formed inside fixed mammalian cells on maltose binding pro-
tein (MBP) modified with 27 and fluorescent tetrazine conju-
gate Cy5-6. Later, live-cell labelling of intracellular GFPY39TAG!27
was established as well with fluorogenic siliconrhodamine SiR-
3b derivative in E. coli.[52] The fluorogenicity of SiR probes
relies on spirolactone formation of the carboxylate group,
which quenches the fluorescence in a polarity-dependent
manner. Not only the above mutant, but also wild-type PylRS/
tRNAPyl could also be used to encode 25.[53] Lang et al. de-
Scheme 10. Structures of noncanonical amino acids used as building blocks for fluorescent protein labelling in IEDDA.
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scribed live-cell membrane labelling of 25-modified epidermal
growth factor receptor (EGFR128TAGGFP) on the surfaces of
mammalian HEK293 cells by using FRET-type fluorogenic
TAMRA-1. Kaya et al. described the use of a triple-mutant
Y384F/Y306G/I405R PylRSFGR/tRNAPyl pair to encode 26 into
human polymerase k (hPolk).[54] In addition to reactions with
nitrile imines and tetrazoles, they performed IEDDA labelling
schemes on purified 26-hPolk.
The Chin group discovered further engineered PylRS/tRNAPyl
pairs capable of encoding TCO-Lys (27) and BCN-Lys (28).[27b]
The lysine derivative of the fastest known TCO to date—s-TCO-
Lys (29)—was also included in the study; however, due to its
isomerization to the unreactive cis form in the thiol-rich cellular
environment, it was not possible to apply it in live-cell label-
ling. TCO-Lys (27), however, was successfully applied to label
EGFR128TAG with TAMRA-1, and BCN-Lys (28)[55] was also used in
an intracellular labelling scheme of transcription factor protein
jun with a cell-permeable fluorescein–3 probe in HEK293 cell
nuclei.
Although lysine is the most commonly used amino acid to
which IEDDA tags are conjugated, tyrosine derivatives of nor-
bornene, SCO and TCO are also known (30–34). The Tyr deriva-
tives were genetically encoded into GFP by employing an
evolved PylRS/tRNAPyl pair (Y306A, N346A, C348A, Y384F) in
E. coli and applied in IEDDA with fluorescein–3 as well as in
1,3-cycloaddition with hydrazonoyl chloride.[56]
The smallest strained dienophile system that has been en-
coded into proteins is cyclopropene, in Cp-Lys (35).[57] Al-
though this system has slower reaction kinetics than cyclooc-
tynes or TCOs, it was found to be applicable in proteomics be-
cause it causes minimal perturbation to protein structures and
synthesis. Elliott et al. developed SORT-M (stochastic orthogo-
nal recording of translation with chemoselective modification)
by use of tRNAPyls with modified sense-decoding anticodons to
perform proteome-wide labelling.[58] This approach was applied
to Drosophila melanogaster to label and to image proteins with
Alexa647-1 in specific tissues at precise developmental stages.
It allowed the identification of proteins synthesized in germ
cells of the fly ovary without dissection. Genetic encoding of
unstrained olefins was reported by Lee et al.[59] Fluorescent la-
belling of terminal alkenyllysine (36 and 37) and -tyrosine (38
and 39) derivatives with fluorescein-3a probe was performed
on E. coli outer membrane protein OmpX, though with slug-
gish reaction rate constants (&3V10@2m@1 s@1). In the array of
biological building blocks suitable for IEDDA, dienophile-ap-
pended derivatives are mostly the reaction partners of choice,
due to their generally higher stability over tetrazines. Genetic
encoding of stable tetrazine-containing ncAAs, however, was
described by the Mehl group. They developed the M. janna-
schii tyrosyl tRNA synthetase/tRNACUA pair to incorporate 40
into GFP150TAG in E. coli.[60] Kinetic studies showed moderate re-
action rates with s-TCO (880m@1 s@1 in vitro and 330m@1 s@1 in
vivo) and d-TCO isomers (95 and 99m@1 s@1 in vitro), measured
by the increment of quenched GFP fluorescence caused by
FRET between the GFP and the tetrazine moiety (labs=
520 nm).[11,60] Conjugate 40–GFP was labelled with diacetyl-
fluorescein-s-TCO. Removal of the amine linkage between the
phenyl ring and the tetrazine led to the development of 41,
with greatly improved stability and reactivity (72500m@1 s@1 in
vivo with s-TCO).[61] The 41-GFP conjugate was selectively la-
belled with TAMRA-s-TCO in E. coli cell lysate.
In spite of their high reactivity and stability, there are no
reports on live-cell labelling with tetrazine-ncAAs. However, 40
was successfully applied in vitro in a site-specific double-label-
ling scheme.[62] To encode different amino acids at different
sites in a single protein, an orthogonal ribosome (ribo-Q1) that
recognizes quadruplet-decoding PylRS/tRNA and amber-de-
coding MjTyrRS/tRNA was developed.[63] This enabled genetic
incorporation of 40 and 25 into calmodulin (modified at posi-
tion 1 with UAG amber and at position 40 with AGTA quadru-
plet codon) by using evolved MjTyrRS/tRNACUA and PylRS/
tRNAUACU, respectively.
[62] The ncAAs did not cross-react with
each other in the protein and permitted selective double label-
ling with BODIPY-TMR-X-BCN and BODIPY-FL-1 at the tetrazine
and norbornene residues, respectively. FRET between the two
fluorescent labels in the presence of increasing concentrations
of urea allowed probing of calmodulin’s structure and dynam-
Figure 2. Double labelling of calmodulin. A) Amber suppression is used to
encode 40, whereas 25 is incorporated in response to a quadruplet codon.
Double labelling is performed with dyes based on BCN and 1, respectively.
B) Probing calmodulin dynamics by detecting FRET in the presence of in-
creasing urea concentrations. Reprinted in part and with permission from
ref. [62] . Copyright: 2014, Nature Publishing Group.
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ics (Figure 2). This example demonstrated the power of using
two IEDDA reactions in parallel fashion for site-specific modifi-
cation of proteins on purified samples.
Nikic´ et al. applied dual-colour labelling to live cells by
taking advantage of different reaction kinetics of two sets of
dienophile/tetrazine pairs.[64] They synthesized TCO-ncAAs
(TCO*-Lys, TCO#-Lys) that showed improved stability and re-
activity towards tetrazine probes 3a and 3b. Initial attempts
combining strain-promoted 1,3-dipolar cycloaddition (BCN/
azide) and IEDDA (TCO*/tetrazine) reactions for dual labelling
led to high background caused by the slow reaction kinetics of
azide–alkyne cycloaddition. However, combining TCO*-Lys and
SCO(a)-Lys encoded in a time-dependent manner in response
to amber stop codons paved the way for dual-colour IEDDA
labelling by using fluorescent tetrazine conjugates. In pulse-
chase labelling experiments, Cy5-3b reacts selectively with
TCO*-Lys and shows no substantial reactivity with SCO(a)-Lys,
whereas Atto532-3a reacts with SCO(a)-Lys rapidly.
The reactivity difference between SCO/TCO* and 3a/3b is
due to the steric hindrance of the methyl group at the tetra-
zine moiety as well as the different carbamate conjugation po-
sitions.[8] Furthermore, the two dyes allowed dual-colour super-
resolution microscopy study of insulin receptors and virus-like
nanoparticles expressed at different times on the surfaces of
mammalian HEK293T cells (Figure 3A).
As mentioned above, IEDDA-mediated protein labelling has
been used to study cell-surface proteins in several cases. Intra-
cellular applications, however, are limited, mainly due to the
hydrophobicity of the dienophile-ncAAs. Residual ncAAs in the
cytoplasm and the nuclei of live cells cause high background
in fluorescent tetrazine labelling. To address this problem, Utta-
mapinant et al. applied BCN-Lys in intracellular labelling of
skeletal proteins actin and vimentin in combination with a fluo-
rogenic SiR-3a dye (Figure 3B).[65] BCN-Lys is slightly more hy-
drophilic than TCO*-Lys, and this resulted in better clearance
of the non-incorporated ncAA from the intracellular compart-
ments, but prolonged (>6 h) washes before fluorescent label-
ling were still required.
To extend the applicability of IEDDA cycloaddition in intra-
cellular labelling, our group developed a set of new hydrophil-
ic TCO and cyclooctyne derivatives, of which dioxo derivative
DOTCO-Lys (44, Scheme 10) showed high incorporation effi-
ciency with PylRSAF/tRNAPyl.[17] We performed a washout experi-
ment to detect residual ncAAs in the cytoplasm (Figure 4). Effi-
cient removal of hydrophobic TCO*-Lys from the cytoplasm
was not possible, even after 6 h of washing. Slightly more hy-
drophilic BCN-Lys gave almost no background, but only after
6 h of washing. Hydrophilic DOTCO-Lys, on the other hand,
was easily removed from the cytoplasm after 5 min of washing.
The greatly improved hydrophilicity of DOTCO-Lys enabled
fluorescent labelling of intracellular lymphocytic protein SLP76-
YFP40TAG with Cy5-3 after only 15 min washing. Another ap-
proach to achieve low background in intracellular labelling in-
volves application of fluorogenic tetrazine probes. We devel-
oped six phenoxazine-tetrazine fluorogenic probes based on
TBET-quenching through phenyl or vinyl linkers (e.g. , phenoxa-
zine-Me-Tz, Scheme 3). Site-specifically TCO*-modified GFP tag-
ging was established with these probes in vivo in mammalian
HEK293T cells with very low background signal.[28c]
A highly appealing advantage of using genetic code expan-
sion technology combined with IEDDA cycloaddition is that it
paves the way to imaging of proteins, which previously were
impossible to visualize. In a very recent paper, Peng and Hang
used the axial isomer of TCO*-Lys to image interferon-induci-
ble transmembrane protein 3 (IFITM3), a vesicle-associated
membrane protein involved in host restriction of viruses.[66]
IFITM3 contains only 137 amino acids and so is only around
half the size of fluorescent proteins such as GFP. Thus, it is not
surprising that it has not been possible to image IFITM3 in live
cells with GFP because fusion proteins disrupted IFITM3 cellu-
lar localization and antiviral activity. However, genetic encoding
of TCO*-Lys and subsequent labelling with BODIPY-FL-3a led
to successful imaging of localization and trafficking of IFITM3
in live cells (Figure 5).
5. Fluorescent Glycan Labelling through
Metabolic Engineering
Sugar-modified proteins—that is, glycans—mediate several
biological processes in cellular physiology: they play key roles
in molecular recognition, protein trafficking, bacterial and viral
infection and intercellular communication.[67] It is known that
the structures of glycans, which decorate all eukaryotic cell sur-
faces, change with the onset of cancer and inflammation.[68]
Unlike protein and nucleic acid production, which is genetically
encoded, glycosylation is a posttranslational modification.
Thus, techniques developed to label nucleic acids and proteins
are not directly transferrable to label glycans. Lectins (receptor
proteins for glycans) and antibodies can be used to probe gly-
cosylation at a global level. However, they are limited by their
low specificity, low affinity and lack of permeability. Besides,
they are restricted to in vitro applications. We provide a brief
overview of the recent developments in chemical probing of
glycans through IEDDA cycloaddition, which have enabled
studies in living systems through modification of monosacchar-
ide residues.
Metabolic oligosaccharide engineering (MOE) involves chem-
ically synthesizing a monosaccharide analogue and feeding
cells with this unnatural monosaccharide, which is processed
similarly to its native counterpart and integrated into cellular
glycans. This approach depends on the selection of a reporter
group that can readily be installed onto monosaccharide
substrates with minimal perturbation to their structures. The
reporter is detected in a second step through bio-orthogonal
chemistry. While powerful, this strategy has been limited to
only a handful of functional groups. There are numerous exam-
ples of azide-, alkyne- and ketone-modified unnatural sugars
and their subsequent bio-orthogonal labelling with alkynes,
azides and soft nucleophiles (e.g. , through Bertozzi–Staudinger
ligation), respectively.[69] Because of their higher reaction rates,
IEDDA reactions have found numerous applications in glycan
labelling schemes as well. The first IEDDA reaction performed
on glycans was employed by Patterson et al. ,[18] who showed
that methylcyclopropene units could be directly conjugated to
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N-acetylneuraminic acid (NeuAc) and incorporated into cell-sur-
face glycans. Jurkat cells were incubated with 9-Cp-NeuAc for
24–48 h and subsequently treated with a biotin-1 conjugate
(100 mm for 1 h; for structures of unnatural sugars, see
Scheme 11). Subsequent avidin staining allowed examination
of glycan labelling by flow cytometry. Although the measured
reaction rates were slow—in the 0.05m@1 s@1 range, for exam-
ple—they are comparable with those of the SPAAC and Bertoz-
zi–Staudinger ligation reactions.
Figure 3. Site-specific fluorescent labelling of proteins through IEDDA cycloaddition enables super-resolution microscopy. A) Cell-membrane dual-labelling of
insulin receptors: schematic two-step cell labelling protocol and GSDIM images of double-labelled insulin receptors. B) Intracellular labelling of actin filaments
and subsequent STORM imaging. Figure 3A is reproduced in part and with permission from ref. [64] . Copyright : 2014, John Wiley & Sons, Inc. Figure 3B is re-
printed with permission from ref. [65] . Copyright : 2015, American Chemical Society.
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Shortly after, Cole et al. reported on a cyclopropenylated
derivative of mannosamine, a metabolic precursor for sialic
acid.[70] Peracetylated N-acyl cyclopropene mannosamine
(Ac4ManNCyc, 46, Scheme 11) was metabolized and efficiently
incorporated by human cancer cells. Cyclopropene-tagged cell-
surface glycans could subsequently be labelled with Alexa-
Fluor488-3a and visualized by confocal microscopy.
These first examples described IEDDA-mediated glycan label-
ling; however, in both reports low incorporation efficiency of
cyclopropene-sugars was a limiting factor. Indeed, the N-acyl
derivatization in 9-Cp-NeuAc and Ac4ManNCyc is located at the
b-carbon atom, though it has been reported that b-N-acyl sub-
stitution is not well tolerated by the sialic acid biosynthetic
machinery.[71] Moreover, electron-withdrawing groups (e.g. ,
amides) at C3 reduce reaction rates of cyclopropenes in IEDDA
cycloaddition.
To improve cyclopropene glycan tagging rates, Sp-te et al.
and Patterson et al. simultaneously reported cyclopropene-
mannosamine derivative Ac4ManCCyc (47, Scheme 1), with a
carbamate linker.[72] This slight change in the sugar structure
greatly improved the metabolic incorporation efficiency, and
the IEDDA reaction rate as well (0.99m@1 s@1), leading to a 130-
fold improvement in fluorescent labelling efficiency. Further-
more, derivatization through direct conjugation of aminosu-
gars with an activated cyclopropene unit improved synthetic
availability. Visualization of Ac4ManCCyc-modified glycans in
mammalian cell surfaces by confocal microscopy was possible
after only 5 min staining with 25 mm Cy3-6. The IEDDA tagging
scheme was extended to other monosaccharides. For example,
visualization of mucin-type O-glycoproteins with Ac4GalCCyc
and of O-GlcNAcylated proteins with Ac4GlcCCyc were also
performed; however, efficiency rates lagged behind those of
sialic acid labelling.
Recently, Doll et al. used Ac4ManCCyc to study the glycosyla-
tion states of specific intracellular proteins [O-GlcNAc transfer-
ase (OGT), transcription factor Foxo1, tumour suppressor p53,
serine/threonine kinase Akt1, actin-binding protein vinculin
and calcium/calmodulin-dependent protein kinase CAMK4] in
live cells.[73] The target proteins were tagged with GFP and
overexpressed in HEK293T cells incubated in Ac4ManCCyc-
containing medium. FRET between GFP and TAMRA-3-tagged
glycan was detected by fluorescence lifetime imaging micros-
Figure 4.Washout assay of ncAAs: experimental demonstration that nonspecific background in intracellular labelling is directly linked to the hydrophilicity of
the ncAA. A) Confocal microscopy images of non-transfected COS7 cells washed for different times before labelling with TAMRA-3. B) Quantitative analysis. Re-
produced in part and with permission from ref. [17] . Copyright : 2016, John Wiley & Sons, Inc.
Figure 5. Timelapse imaging of the fusion process of IFITM-containing vesicles with dextran particles. IFITM3-TCO*-Lys was labelled with BODIPY-FL-3a, and
dextran particles were labelled with pHrodo Red. Reprinted with permission from ref. [66] . Copyright: 2016, American Chemical Society.
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copy (FLIM). This approach revealed nuclear localization and
regulation of Akt1 by O-GlcNAcylation. This was the first dem-
onstration of examination of protein glycosylation states within
living cells, stressing the power of bio-orthogonal chemistry.
A great advantage of cyclopropene-tetrazine labelling is that
it is reported to be orthogonal with azide–alkyne cycloaddi-
tion. This was exploited in targeting unique subsets of cellular
glycans by dual-colour labelling. For example, Sp-te et al. treat-
ed HEK293T cells with both Ac4ManCCyc (to target sialated
structures) and Ac4GlcNAz (an azido derivative of GlcNAc).
[74a]
The cells were treated concurrently with Cy3-6 and DIBO-488
for 15 min. Clear membrane staining in both IEDDA and SPAAC
channels indicated the orthogonality of the two reactions in
glycan labelling (Figure 6). The same authors recently reported
a series of norbornene-tagged mannosamine derivatives suita-
ble for metabolic engineering of glycan structures. They also
demonstrated the dual-colour labelling potential of these de-
rivatives in combination with SPAAC chemistry.[74b]
To expand the scope of dienophiles, terminal alkenes were
employed to visualize cell-surface glycans by Niederweisser
et al.[75] Mannosamine derivatives with a pentenoyl
(Ac4ManNPtl, Ac4ManNPeoc) or hexenoyl (Ac4ManNHxl) side
chain were accepted by sialic acid biosynthetic enzymes and
incorporated on the surfaces of HEK293T cells. Live-cell tagging
with biotin-6 was performed, although the low reaction rates
(0.02–0.04m@1 s@1) required high concentrations (1 mm) of the
tagging agent and a long incubation period (i.e. , 6 h) before
fluorescent labelling with AlexaFluor647-biotin. The authors
also synthesized carbamate-linked monosaccharides
(Ac4ManNPeoc), which were tolerated by the biosynthetic en-
zymes. In a later report, the same group optimized the alkene
side chain of the carbamate-linked mannosamine derivative to
a butenyl moiety (Ac4ManNBeoc).
[21] Still, reaction rates could
be tuned only up to 0.074m@1 s@1 with tetrazine 6.
Isonitriles were also installed onto monosaccharides for
IEDDA labelling applications with tetrazines by the Leeper
group.[76] Primary isonitrile-modified glucosamine (Ac4GlcN-n-
Iso) and mannosamine (Ac4ManN-n-Iso) were successfully in-
corporated into glycans of Lewis lung carcinoma (LL2) cells
and labelled sequentially with biotin-1 and NA647. Interesting-
ly, the reaction could not be extended to tertiary isonitrile-
modified sugars, either due to the instability of this species or
because of incompatibility with the metabolic machinery.
Although isonitrile-tetrazine and unstrained alkene-tetrazine
glycan labelling approaches were both orthogonal with azide–
alkyne labelling in dual-colour imaging applications, these
approaches did not find wider applications, due to their low
reaction rates.
Despite advancements in IEDDA-based glycan-labelling,
eight-membered strained alkenes or alkynes were thought to
be impossible to utilize as glycobiology building blocks, due,
Scheme 11. Structures of bio-orthogonalized monosaccharides for fluorescent glycan labelling through IEDDA cycloaddition enabled by metabolic oligosac-
charide engineering.
Figure 6. Double labelling of cell-surface glycans through IEDDA and SPAAC.
A) Labelling strategy, based on metabolic incorporation of Ac4ManCCp and
Ac4GlcNAz and subsequent labelling with Cy3-6 and AF488-DIBO. B) Confo-
cal microscopy images of doubly labelled cell-surface glycans on HEK293T
cells. Reprinted with permission from ref. [74a] . Copyright: 2014, American
Chemical Society.
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in part, to their large size and incompatibility with many en-
dogenous biosynthetic pathways. In 2015, however, Agarwal
et al. exploited sialic acid biosynthetic enzymes’ fortuitous tol-
erance of bulky substituents at the C5 and C9 positions.[77]
They prepared a BCN-functionalized sialic acid derivative
(BCNSia) and showed by flow cytometry that BCNSia is incor-
porated into mammalian glycoproteins and can be labelled by
tetrazine probes with higher labelling efficiency than SPAAC of
azidosugars. This is most probably due to the advantageous
features of IEDDA labelling schemes, because the incorpora-
tion efficiencies of BCN-ylated sugars are lower than those of
smaller tags (e.g. , azide). In zebrafish embryos, strong BCNSia-
dependent labelling was observed on injection of a TBET-
based fluorogenic Oregon green vinyltetrazine probe
(Scheme 3, Figure 7). This enabled mapping of the sialyation
pattern of zebrafish embryos and hence the identification of
several new sialylated structures in developing zebrafish em-
bryos, raising questions about tissue-specific sialyl-transferase
activity.
6. Concluding Remarks
Inverse-electron-demand Diels–Alder reactions between tetra-
zines and various dienophiles have been shown to represent
a very efficient approach in bio-orthogonally driven manipula-
tion of biomolecules. Several detailed studies and develop-
ments resulted in an array of tetrazine and dienophile scaffolds
that can be used for selective and fast labelling of virtually any
kind of biomolecule in vivo. This is in contrast to other meth-
ods that are limited either to species directly encoded in the
genome (e.g. , fusion-protein-based labelling techniques) or
suitable only for in vitro or extracellular labelling studies (e.g. ,
Ig-based labelling schemes). The different reactivities and sta-
bilities of these reagents can be exploited by using the most
suitable tetrazine/dienophile combinations, allowing us to
choose those that suit the best for the needs of the particular
chemical biology task. Here we have put special emphasis on
applications directed towards fluorescent modification of vari-
ous biopolymers by use of unnatural building blocks. The ex-
amples presented here aim to show the great potential that
lies behind IEDDA-based bio-orthogonal fluorescent labelling
schemes. Selective and site-specific or even multicolour label-
ling of nucleic acids, proteins, lipids or glycan structures
became possible with this rediscovered chemistry.
Although the use of IEDDA labelling schemes can overcome
many of the obstacles that might corrupt fluorescent imaging
of live cells, for example, by enabling the use of lower probe
concentrations or the use of fluorogenic NIR probes, there is
still room for more improvements. For specific, site-selective in
vivo tagging schemes, special attention should be devoted to
the development of intracellularly applicable, nontoxic, mem-
brane-permeable, IEDDA-suitable labels. To provide finer details
of investigated biomolecular processes, an increase in the
number of probes that enable super-resolution imaging is also
required. Besides being suitable for IEDDA tagging such
probes need to be bright, photostable, reversibly switchable or
fluorogenic.
Another approach to lowering background signal requires
the development of hydrophilic dienophiles with suitable reac-
tivity. This mainly involves the development of hydrophilic TCO
derivatives because these offer the highest reaction speeds
and are limited mostly by their hydrophobic nature. An appre-
ciably large set of hydrophilic TCO derivatives also makes more
likely the development of TCO-modified noncanonical amino
acids that are recognized by orthogonal tRNARS/tRNA pairs or
of TCO-tagged small-molecule metabolites that are tolerated
by the metabolic machinery of the particular system.
As presented in the form of a few examples, combination of
mutually orthogonal chemistries—IEDDA with SPAAC or two
Figure 7. Metabolic incorporation of BCNSia into zebrafish embryos and sub-
sequent labelling with fluorogenic Oregon green tetrazine dye. A) Schematic
representation of expected metabolic pathway for the incorporation of
BCNSia into cell-surface glycans and subsequent labelling. CMAS: cytidine
monophosphate N-acetylneuraminic acid. CMP: cytidine monophosphate.
B) Schematic representation of labelling protocol. Zebrafish embryos were
injected with BCNSia and then with fluorogenic tetrazine in the caudal vein.
C) Projection images of 48 hpf (hours post-fertilisation) embryos treated
with BCNSia or vehicle; fluorogenic tetrazine was coinjected with AF647-NH2
to map the vasculature. Scale bar: 200 mm. Reproduced in part, with permis-
sion, from ref. [77] . Copyright : 2015, John Wiley & Sons, Inc.
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IEDDA reactions with different reactivities, for example—ena-
bles two-colour labelling schemes. Development of more or-
thogonal reactions would allow multicolour imaging applica-
tions. The large number of dienophiles and their finely tune-
able reactivities in combination with tetrazines with different
reactivities suggest that this chemistry should be suitable to
explore multiply orthogonal transformations.
Although not covered in this review, a promising field in
bio-orthogonal chemistry is the development of nanoparticle
systems that allow combined, multimodal imaging (e.g. , fluo-
rescence-PET, fluorescence-MRI, etc.). Such nanoparticles could
also be used as platforms for targeting elements and cargos
for drugs simultaneously. Installation of such multiple design
elements becomes possible with the use of multiple orthogo-
nal chemistries. Different tetrazine/dienophile pairs can offer
such multi-functionalization in the context of the same chemis-
try; however, IEDDA in combination with, for example, SPAAC
can also be considered.
Briefly, existing tetrazine-based fluorescent or fluorogenic
probes in combination with dienophile-modified building
blocks bring us closer to a more comprehensive understanding
of living systems. Seeing the whole picture more clearly per-
mits us to understand the essence of biomolecular processes.
Acknowledgements
This work was supported by the Hungarian Scientific Research
Fund (OTKA, NN-116265) and the “Lendelet” Program of the Hun-
garian Academy of Sciences (LP2013-55/2013).
Keywords: bio-orthogonal building blocks · cycloaddition ·
dienophiles · fluorescence · inverse-electron-demand Diels–
Alder reaction · tetrazines
[1] E. Saxon, C. R. Bertozzi, Science 2000, 287, 2007–2010.
[2] a) E. M. Sletten, C. R. Bertozzi, Angew. Chem. Int. Ed. 2009, 48, 6974–
6998; Angew. Chem. 2009, 121, 7108–7133; b) D. M. Patterson, L. A.
Nazarova, J. A. Prescher, ACS Chem. Biol. 2014, 9, 592–605; c) C. P.
Ramil, Q. Lin, Chem. Commun. 2013, 49, 11007–11022.
[3] a) J. Sauer, D. K. Heldmann, J. Hetzenegger, J. Krauthan, H. Sichert, J.
Schuster, Eur. J. Org. Chem. 1998, 2885–2896; b) D. L. Boger, S. M.
Sakya, J. Org. Chem. 1988, 53, 1415–1423; c) “1, 2,4,5-Tetrazines”, J.
Sauer in Comprehensive Heterocyclic Chemistry II, Vol. 6 (Series eds. : A. R.
Katritzky, C. W. Rees, E. F. V. Scriven), Pergamon, Oxford, 1996, pp. 901–
957; d) D. L. Boger, R. S. Coleman, J. S. Panek, D. Yohannes, J. Org. Chem.
1984, 49, 4405–4409.
[4] M. L. Blackman, M. Royzen, J. M. Fox, J. Am. Chem. Soc. 2008, 130,
13518–13519.
[5] N. K. Devaraj, R. Weissleder, S. A. Hilderbrand, Bioconjugate Chem. 2008,
19, 2297–2299.
[6] R. A. Carboni, R. V. Lindsey, J. Am. Chem. Soc. 1959, 81, 4342–4346.
[7] a) A.-C. Knall, C. Slugovc, Chem. Soc. Rev. 2013, 42, 5131–5142; b) H.
Wu, N. Devaraj, Top. Curr. Chem. 2016, 374, 1–22; c) A. M. Prokhorov,
D. N. Kozhevnikov, Chem. Heterocyc. Compd. 2012, 48, 1153–1176.
[8] J. A. Wagner, D. Mercadante, I. Nikic´, E. A. Lemke, F. Gr-ter, Chem. Eur. J.
2015, 21, 12431–12435.
[9] Y. Liang, J. L. Mackey, S. A. Lopez, F. Liu, K. N. Houk, J. Am. Chem. Soc.
2012, 134, 17904–17907.
[10] G. B. Cser8p, O. Demeter, E. B-tzner, M. K#llay, H.-A. Wagenknecht, P.
Kele, Synthesis 2015, 2738–2744.
[11] A. Darko, S. Wallace, O. Dmitrenko, M. M. Machovina, R. A. Mehl, J. W.
Chin, J. M. Fox, Chem. Sci. 2014, 5, 3770–3776.
[12] M. Royzen, G. P. A. Yap, J. M. Fox, J. Am. Chem. Soc. 2008, 130, 3760–
3761.
[13] M. T. Taylor, M. L. Blackman, O. Dmitrenko, J. M. Fox, J. Am. Chem. Soc.
2011, 133, 9646–9649.
[14] N. J. Agard, J. A. Prescher, C. R. Bertozzi, J. Am. Chem. Soc. 2004, 126,
15046–15047.
[15] J. Dommerholt, S. Schmidt, R. Temming, L. J. Hendriks, F. P. Rutjes, J. C.
van Hest, D. J. Lefeber, P. Friedl, F. L. van Delft, Angew. Chem. Int. Ed.
2010, 49, 9422–9425; Angew. Chem. 2010, 122, 9612–9615.
[16] a) I. Nikic´, T. Plass, O. Schraidt, J. Szyman´ski, J. A. Briggs, C. Schultz, E. A.
Lemke, Angew. Chem. Int. Ed. 2014, 53, 2245–2249; Angew. Chem. 2014,
126, 2278–2282; b) J. E. Hoffmann, T. Plass, I. Nikic´, I. V. Aramburu, C.
Koehler, H. Gillandt, E. A. Lemke, C. Schultz, Chem. Eur. J. 2015, 21,
12266–12270; c) R. M. Versteegen, R. Rossin, W. ten Hoeve, H. M. Jans-
sen, M. S. Robillard, Angew. Chem. Int. Ed. 2013, 52, 14112–14116;
Angew. Chem. 2013, 125, 14362–14366; d) J. Li, S. Lia, P. R. Chen, Nat.
Chem. Biol. 2014, 10, 1003–1005; e) X. Fan, Y. Ge, F. Lin, Y. Yang, G.
Zhang, W. S. C. Ngai, Z. Lin, S. Zheng, J. Wang, J. Zhao, J. Li, P. R. Chen,
Angew. Chem. Int. Ed. 2016, 55, 14046–14050; Angew. Chem. 2016, 128,
14252–14256.
[17] E. Kozma, I. Nikic´, B. R. Varga, I. V. Aramburu, J. H. Kang, O. T. Fackler,
E. A. Lemke, P. Kele, ChemBioChem 2016, 17, 1518–1524.
[18] J. Yang, Y. Liang, J. Sˇecˇkute˙, K. N. Houk, N. K. Devaraj, Chem. Eur. J. 2014,
20, 3365–3375.
[19] D. M. Patterson, L. Nazarova, B. Xie, D. Kamber, J. A. Prescher, J. Am.
Chem. Soc. 2012, 134, 18638–18643.
[20] S. B. Engelsma, L. I. Willems, C. E. van Paaschen, S. I. van Kasteren, G. A.
van der Marel, H. S. Overkleeft, D. V. Filippov, Org. Lett. 2014, 16, 2744–
2747.
[21] A.-K. Sp-te, V. F. Schart, S. Schçllkopf, A. Niederwieser, V. Wittmann,
Chem. Eur. J. 2014, 20, 16502–16508.
[22] S. Eising, F. Lelivelt, K. M. Bonger, Angew. Chem. Int. Ed. 2016, 55,
12243–12247; Angew. Chem. 2016, 128, 12431–12435.
[23] a) C. Denk, D. Svatunek, T. Filip, T. Wanek, D. Lumpi, J. Frçhlich, C. Kunt-
ner, H. Mikula, Angew. Chem. Int. Ed. 2014, 53, 9655–9659; Angew.
Chem. 2014, 126, 9810–9814; b) C. Denk, D. Svatunek, S. Mairinger, J.
Stanek, T. Filip, D. Matscheko, C. Kuntner, T. Wanek, H. Mikula, Bioconju-
gate Chem. 2016, 27, 1707–1712; c) N. K. Devaraj, G. M. Thurber, E. J.
Keliher, B. Marinelli, R. Weissleder, Proc. Natl. Acad. Sci. USA 2012, 109,
4762–4767.
[24] a) B. M. Zeglis, K. K. Sevak, T. Reiner, P. Mohindra, S. D. Carlin, P. Zanzoni-
co, R. Weissleder, J. S. Lewis, J. Nucl. Med. 2013, 54, 1389–1396; b) H. L.
Evans, L. Carroll, E. O. Aboagye, A. C. Spivey, J. Labelled Compd. Radio-
pharm. 2014, 57, 291–297; c) B. Nichols, Z. Qin, J. Yang, D. R. Vera, N. K.
Devaraj, Chem. Commun. 2014, 50, 5215–5217.
[25] G. B. Cser8p, A. Herner, P. Kele, Methods Appl. Fluoresc. 2015, 3, 042001.
[26] a) D. S. Liu, A. Tangpeerachaikul, R. Selvaraj, M. T. Taylor, J. M. Fox, A. Y.
Ting, J. Am. Chem. Soc. 2012, 134, 792–795; b) R. S. Erdmann, H. Taka-
kura, A. D. Thompson, F. Rivera-Molina, E. S. Allgeyer, J. Bewersdorf,
D. K. Toomre, A. Schepartz, Angew. Chem. Int. Ed. 2014, 53, 10242–
10246; Angew. Chem. 2014, 126, 10407–10412.
[27] a) N. K. Devaraj, S. Hilderbrand, R. Upadhyay, R. Mazitschek, R. Weissled-
er, Angew. Chem. Int. Ed. 2010, 49, 2869–2872; Angew. Chem. 2010, 122,
2931–2934; b) K. Lang, L. Davis, S. Wallace, M. Mahesh, D. J. Cox, M. L.
Blackman, J. M. Fox, J. W. Chin, J. Am. Chem. Soc. 2012, 134, 10317–
10320.
[28] a) J. C. Carlson, L. G. Meimetis, S. A. Hilderbrand, R. Weissleder, Angew.
Chem. Int. Ed. 2013, 52, 6917–6920; Angew. Chem. 2013, 125, 7055–
7058; b) H. Wu, J. Yang, J. Sˇecˇkute˙, N. K. Devaraj, Angew. Chem. Int. Ed.
2014, 53, 5805–5809; Angew. Chem. 2014, 126, 5915–5919; c) L. G. Mei-
metis, J. C. Carlson, R. J. Giedt, R. H. Kohler, R. Weissleder, Angew. Chem.
Int. Ed. 2014, 53, 7531–7534; Angew. Chem. 2014, 126, 7661–7664;
d) G. Knorr, E. Kozma, A. Herner, E. A. Lemke, P. Kele, Chem. Eur. J. 2016,
22, 8972–8979; e) A. Wieczorek, P. Werther, J. Euchner, R. Wombacher,
Chem. Sci. 2017; DOI: 10.1039/C6SC03879D.
[29] a) J. Schoch, M. Wiessler, A. J-schke, J. Am. Chem. Soc. 2010, 132, 8846–
8847; b) J. Schoch, S. Ameta, A. J-schke, Chem. Commun. 2011, 47,
12536–12537.
ChemBioChem 2017, 18, 486 – 501 www.chembiochem.org T 2017 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim500
Minireviews
[30] J. Schoch, M. Staudt, A. Samanta, M. Wiessler, A. J-schke, Bioconjugate
Chem. 2012, 23, 1382–1386.
[31] A. Pyka, C. Domnick, F. Braun, S. Kath-Schorr, Bioconjugate Chem. 2014,
25, 1438–1443.
[32] P. N. Asare-Okai, E. Agustin, D. Fabris, M. Royzen, Chem. Commun. 2014,
50, 7844–7847.
[33] K. Wang, D. Wang, K. Ji, W. Chen, Y. Zheng, C. Dai, B. Wang, Org. Biomol.
Chem. 2015, 13, 909–915.
[34] X. Ren, A. H. El-Sagheer, T. Brown, Analyst 2015, 140, 2671–2678.
[35] U. Rieder, N. W. Luedtke, Angew. Chem. Int. Ed. 2014, 53, 9168–9172;
Angew. Chem. 2014, 126, 9322–9326.
[36] H. Bußkamp, E. Batroff, A. Niederwieser, O. S. Abdel-Rahman, R. Winter,
V. Wittmann, A. Marx, Chem. Commun. 2014, 50, 10827–10829.
[37] L. Li, M. Degardin, T. Lavergne, D. A. Malyshev, K. Dhami, P. Ordoukhani-
an, F. E. Romesberg, J. Am. Chem. Soc. 2014, 136, 826–829.
[38] F. Eggert, S. Kath-Schorr, Chem. Commun. 2016, 52, 7284–7287.
[39] C. Domnick, F. Eggert, S. Kath-Schorr, Chem. Commun. 2015, 51, 8253–
8256.
[40] M. Merkel, S. Arndt, D. Ploschik, G. B. Cser8p, U. Wenge, P. Kele, H.-A.
Wagenknecht, J. Org. Chem. 2016, 81, 7527–7538.
[41] J. Sˇecˇkute˙, J. Yang, N. K. Devaraj, Nucleic Acids Res. 2013, 41, e148.
[42] H. Wu, B. T. Cisneros, C. M. Cole, N. K. Devaraj, J. Am. Chem. Soc. 2014,
136, 17942–17945.
[43] J. Yang, J. Sˇecˇkute˙, C. M. Cole, N. K. Devaraj, Angew. Chem. Int. Ed. 2012,
51, 7476–7479; Angew. Chem. 2012, 124, 7594–7597.
[44] a) D. Jung, K. Min, J. Jung, W. Jang, Y. Kwon, Mol. BioSyst. Mol. Biosys.
2013, 9, 862–872; b) K. Lang, J. W. Chin, Chem. Rev. 2014, 114, 4764–
4806.
[45] a) T. Kimmerlin, D. Seebach, J. Pept. Res. 2008, 65, 229–260; b) P. E.
Dawson, S. B. Kent, Annu. Rev. Biochem. 2000, 69, 923–960; c) C. J.
Noren, S. J. Anthony-Cahill, M. C. Griffith, P. G. Schultz, Science 1989,
244, 182–188.
[46] a) A. J. Link, D. A. Tirrell, J. Am. Chem. Soc. 2003, 125, 11164–11165;
b) D. C. Dieterich, J. J. Lee, A. J. Link, J. Graumann, D. A. Tirrell, E. M.
Schuman, Nat. Protoc. 2007, 2, 532–540; c) K. E. Beatty, F. Xie, Q. Wang,
D. A. Tirrell, J. Am. Chem. Soc. 2005, 127, 14150–14151.
[47] a) C. C. Liu, P. G. Schultz, Annu. Rev. Biochem. 2010, 79, 413–444; b) E. A.
Lemke, ChemBioChem 2014, 15, 1691–1694; c) J. W. Chin, Annu. Rev.
Biochem. 2014, 83, 379–408; d) P. Neumann-Staubitz, H. Neumann,
Curr. Opin. Struct. Biol. 2016, 38, 119–128.
[48] W. Wan, J. M. Tharp, W. R. Liu, Biochim. Biophys. Acta Proteins Proteomics
2014, 1844, 1059–1070.
[49] T. Plass, S. Milles, C. Koehler, C. Schultz, E. A. Lemke, Angew. Chem. Int.
Ed. 2011, 50, 3878–3881; Angew. Chem. 2011, 123, 3964–3967.
[50] T. Yanagisawa, R. Ishii, R. Fukunaga, T. Kobayashi, K. Sakamoto, S. Yoko-
yama, Chem. Biol. 2008, 15, 1187–1197.
[51] T. Plass, S. Milles, C. Koehler, J. Szymanski, R. Mueller, M. Wiessler, C.
Schultz, E. A. Lemke, Angew. Chem. Int. Ed. 2012, 51, 4166–4170;
Angew. Chem. 2012, 124, 4242–4246.
[52] G. Lukinavicˇius, K. Umezawa, N. Olivier, A. Honigmann, G. Yang, T. Plass,
V. Mueller, L. Reymond, I. R. CorrÞa, Z.-G. Luo, C. Schultz, E. A. Lemke, P.
Heppenstall, C. Eggeling, S. Manley, K. Johnsson, Nat. Chem. 2013, 5,
132–139.
[53] K. Lang, L. Davis, J. Torres-Kolbus, C. Chou, A. Deiters, J. W. Chin, Nat.
Chem. 2012, 4, 298–304.
[54] E. Kaya, M. Vrabel, C. Deiml, S. Prill, V. S. Fluxa, T. Carell, Angew. Chem.
Int. Ed. 2012, 51, 4466–4469; Angew. Chem. 2012, 124, 4542–4545.
[55] A. Borrmann, S. Milles, T. Plass, J. Dommerholt, J. M. M. Verkade, M.
Wiessler, C. Schultz, J. C. van Hest, F. L. van Delft, E. A. Lemke, ChemBio-
Chem 2012, 13, 2094–2099.
[56] Y. Kurra, K. A. Odoi, Y.-J. Lee, Y. Yang, T. Lu, S. E. Wheeler, J. Torres-
Kolbus, A. Deiters, W. R. Liu, Bioconjugate Chem. 2014, 25, 1730–1738.
[57] Z. Yu, Y. Pan, Z. Wang, J. Wang, Q. Lin, Angew. Chem. Int. Ed. 2012, 51,
10600–10604; Angew. Chem. 2012, 124, 10752–10756.
[58] T. S. Elliott, F. M. Townsley, A. Bianco, R. J. Ernst, A. Sachdeva, S. J. Els-ss-
er, L. Davis, K. Lang, R. Pisa, S. Greiss, K. S. Lilley, J. W. Chin, Nat. Biotech-
nol. 2014, 32, 465–472.
[59] Y. Lee, Y. Kurra, Y. Yang, J. Torres-Kolbus, A. Deiters, W. R. Liu, Chem.
Commun. 2014, 50, 13085–13088.
[60] J. L. Seitchik, J. C. Peeler, M. T. Taylor, M. L. Blackman, T. W. Rhoads, R. B.
Cooley, C. Refakis, J. M. Fox, R. A. Mehl, J. Am. Chem. Soc. 2012, 134,
2898–2901.
[61] R. J. Blizzard, D. R. Backus, W. Brown, C. G. Bazewicz, Y. Li, R. A. Mehl, J.
Am. Chem. Soc. 2015, 137, 10044–10047.
[62] K. Wang, A. Sachdeva, D. J. Cox, N. W. Wilf, K. Lang, S. Wallace, R. A.
Mehl, J. W. Chin, Nat. Chem. 2014, 6, 393–403.
[63] H. Neumann, K. Wang, L. Davis, M. Garcia-Alai, J. W. Chin, Nature 2010,
464, 441–444.
[64] I. Nikic´, T. Plass, O. Schraidt, J. Szyman´ski, J. A. G. Briggs, C. Schultz, E. A.
Lemke, Angew. Chem. Int. Ed. 2014, 53, 2245–2249; Angew. Chem. 2014,
126, 2278–2282.
[65] C. Uttamapinant, J. D. Howe, K. Lang, V. Ber#nek, L. Davis, M. Mahesh,
N. P. Barry, J. W. Chin, J. Am. Chem. Soc. 2015, 137, 4602–4605.
[66] T. Peng, H. C. Hang, J. Am. Chem. Soc. 2016, 138, 14423–14433.
[67] a) Essentials of Glycobiology, 2nd ed. (Eds. : A. Varki, R. D. Cummings, J. D.
Esko, H. H. Freeze, P. Stanley, C. R. Bertozzi, G. W. Hart, M. E. Etzler), Cold
Spring Harbor Laboratory Press, New York, 2009 ; b) J. A. Prescher, C. R.
Bertozzi, Cell 2006, 126, 851–854.
[68] a) A. Mackiewicz, K. Mackiewicz, Glycoconjugate J. 1995, 12, 241–247;
b) E. Meezan, H. C. Wu, P. H. Black, P. W. Robbins, Biochemistry 1969, 8,
2518–2524; c) D. H. Dube, C. R. Bertozzi, Nat. Rev. Drug Discovery 2005,
4, 477–488.
[69] a) D. Soriano del Amo, W. Wang, H. Jiang, C. Besanceney, A. Yan, M.
Levy, Y. Liu, F. L. Marlow, P. Wu, J. Am. Chem. Soc. 2010, 132, 16893–
16899; b) C. Besanceney-Webler, H. Jiang, T. Zheng, L. Feng, D. Soriano
del Amo, W. Wang, L. M. Klivansky, F. L. Marlow, Y. Liu, P. Wu, Angew.
Chem. Int. Ed. 2011, 50, 8051–8056; Angew. Chem. 2011, 123, 8201–
8206.
[70] C. M. Cole, J. Yang, J. Sˇecˇkute˙, N. K. Devaraj, ChemBioChem 2013, 14,
205–208.
[71] M. R. Bond, H. C. Zhang, J. Kim, S. H. Yu, F. Yang, S. M. Patrie, J. J. Kohler,
Bioconjugate Chem. 2011, 22, 1811–1823.
[72] a) A.-K. Sp-te, V. F. Schart, J. H-fner, A. Niederwieser, T. U. Mayer, V. Witt-
mann, Beilstein J. Org. Chem. 2014, 10, 2235–2242; b) D. M. Patterson,
K. A. Jones, J. A. Prescher, Mol. BioSyst. 2014, 10, 1693.
[73] F. Doll, A. Buntz, A.-K. Sp-te, V. F. Schart, A. Timper, W. Schrimpf, C. R.
Hauck, A. Zumbusch, V. Wittmann, Angew. Chem. Int. Ed. 2016, 55,
2262–2266; Angew. Chem. 2016, 128, 2303–2308.
[74] a) A.-K. Sp-te, H. Bußkamp, A. Niederwieser, V. F. Schart, A. Marx, V. Witt-
mann, Bioconjugate Chem. 2014, 25, 147–154; b) A.-K. Sp-te, J. E. G. A.
Dold, E. Batroff, V. F. Schart, D. E. Wieland, O. R. Baudendistel, V. Witt-
mann, ChemBioChem 2016, 17, 1374–1383.
[75] A. Niederwieser, A.-K. Sp-te, L. D. Nguyen, C. Jengst, W. Reutter, V. Witt-
mann, Angew. Chem. Int. Ed. 2013, 52, 4265–4268; Angew. Chem. 2013,
125, 4359–4363.
[76] a) S. Stairs, A. A. Neves, H. Stçckmann, Y. A. Wainman, H. Ireland-Zecchi-
ni, K. M. Brindle, F. J. Leeper, ChemBioChem 2013, 14, 1063–1067;
b) Y. A. Wainman, A. A. Neves, S. Stairs, H. Stçckmann, H. Ireland-Zecchi-
ni, K. M. Brindle, F. L. Leeper, Org. Biomol. Chem. 2013, 11, 7297–7300.
[77] P. Agarwal, B. J. Beahm, P. Shieh, C. R. Bertozzi, Angew. Chem. Int. Ed.
2015, 54, 11504–11510; Angew. Chem. 2015, 127, 11666–11672.
Manuscript received: November 11, 2016
Accepted Article published: January 10, 2017
Final Article published: February 1, 2017
ChemBioChem 2017, 18, 486 – 501 www.chembiochem.org T 2017 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim501
Minireviews
